PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.\', \'Center for Molecular Biomedicine (CMB), Jena University Hospital, Jena, Germany.\', \'Department of Anesthesiology, Emergency and Intensive Care Medicine, University of Göttingen, Göttingen, Germany.\', \'Infection Biology Unit, German Primate Center-Leibniz Institute for Primate Research, Göttingen, Germany.\', \'Faculty of Biology and Psychology, University Göttingen, Göttingen, Germany.\', \'Department of Nephrology, University of Göttingen, Göttingen, Germany.\', \'Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.784989
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34987511
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34987511>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34987511>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all